{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:50:16Z","timestamp":1791273016176,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ctrv.2025.102880","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T23:39:43Z","timestamp":1737157183000},"page":"102880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Safety of topical estrogen therapy during adjuvant endocrine treatment among patients with breast cancer: A meta-analysis based expert panel discussion"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4470-5267","authenticated-orcid":false,"given":"Stavroula L.","family":"Kastora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3654-335X","authenticated-orcid":false,"given":"Eirini","family":"Pantiora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Hwa","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4955-8270","authenticated-orcid":false,"given":"Meenakshi","family":"Veeramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4344-777X","authenticated-orcid":false,"suffix":"Jr","given":"Hatem A","family":"Azim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6216-5271","authenticated-orcid":false,"given":"Rima","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6239-3856","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2898-1093","authenticated-orcid":false,"given":"Ann","family":"Knoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1797-5296","authenticated-orcid":false,"given":"Matteo","family":"Lambertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1531-630X","authenticated-orcid":false,"given":"Barbro","family":"Linderholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1861-2895","authenticated-orcid":false,"given":"Icro","family":"Meattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4722-4824","authenticated-orcid":false,"given":"Ann H","family":"Partridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7194-2260","authenticated-orcid":false,"given":"Ines","family":"Vaz-Luis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5960-8414","authenticated-orcid":false,"given":"Denise","family":"Vorburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3865-0888","authenticated-orcid":false,"given":"Gabriella","family":"Yongue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3622-3575","authenticated-orcid":false,"given":"Andreas","family":"Karakatsanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6059-0194","authenticated-orcid":false,"given":"Antonios","family":"Valachis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2025.102880_b0005","unstructured":"Who International (https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer) Accessed on the 14.06.2024."},{"key":"10.1016\/j.ctrv.2025.102880_b0010","first-page":"38","article-title":"Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns","volume":"1","author":"Lima","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"12","key":"10.1016\/j.ctrv.2025.102880_b0015","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/ijc.32214","article-title":"Mortality after breast cancer as a function of time since diagnosis by estrogen receptor status and age at diagnosis","volume":"145","author":"Jayasekara","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctrv.2025.102880_b0020","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10549-017-4333-2","article-title":"The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients","volume":"165","author":"Sopik","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"9869","key":"10.1016\/j.ctrv.2025.102880_b0025","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","article-title":"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial","volume":"381","author":"Davies","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2025.102880_b0030","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists' Collaborative Group. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. The Lancet. 2015 Oct 3;386(10001):1341-52.","DOI":"10.1016\/S0140-6736(15)61074-1"},{"issue":"4","key":"10.1016\/j.ctrv.2025.102880_b0035","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.amjsurg.2006.06.018","article-title":"Side effects of aromatase inhibitors versus tamoxifen: the patients\u2019 perspective","volume":"192","author":"Garreau","year":"2006","journal-title":"Am J Surg"},{"issue":"24","key":"10.1016\/j.ctrv.2025.102880_b0040","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMra023246","article-title":"Aromatase inhibitors in breast cancer","volume":"348","author":"Smith","year":"2003","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.ctrv.2025.102880_b0045","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1056\/NEJMra1307118","article-title":"Systemic therapy for estrogen receptor\u2013positive, HER2-negative breast cancer","volume":"383","author":"Burstein","year":"2020","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ctrv.2025.102880_b0050","first-page":"864","article-title":"Breast cancer survivorship, quality of life, and late toxicities","volume":"16","author":"Mouridsen","year":"2020","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2025.102880_b0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1404037","article-title":"Adjuvant exemestane with ovarian suppression in premenopausal breast cancer","volume":"371","author":"Pagani","year":"2014","journal-title":"N Engl J Med"},{"issue":"42","key":"10.1016\/j.ctrv.2025.102880_b0060","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1200\/EDBK_350358","article-title":"Personalizing adjuvant endocrine treatment for early-stage hormone receptor\u2013positive breast cancer","volume":"27","author":"Pistilli","year":"2022","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"27","key":"10.1016\/j.ctrv.2025.102880_b0065","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1200\/JCO.2015.65.8013","article-title":"Subtype-dependent relationship between young age at diagnosis and breast cancer survival","volume":"34","author":"Partridge","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2025.102880_b0070","doi-asserted-by":"crossref","unstructured":"ACOG Committee Opinion No. 659: The Use of Topical Estrogen in Women With a History of Estrogen-Dependent Breast Cancer. Obstet Gynecol. 2016 Mar;127(3):e93-e96. doi: 10.1097\/AOG.0000000000001351. PMID: 26901334.","DOI":"10.1097\/AOG.0000000000001351"},{"key":"10.1016\/j.ctrv.2025.102880_b0075","article-title":"2 (Replaces Committee Opinion Number 659, March 2016): The Use of Topical Estrogen in Women With a History of Estrogen-Dependent","author":"Number","year":"2021","journal-title":"Breast Cancer"},{"issue":"10","key":"10.1016\/j.ctrv.2025.102880_b0080","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/jnci\/djac112","article-title":"Systemic or topical hormone therapy after early breast cancer: a Danish observational cohort study","volume":"114","author":"Cold","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.ctrv.2025.102880_b0085","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10549-023-06871-w","article-title":"Estrogen therapy after breast cancer diagnosis and breast cancer mortality risk","volume":"198","author":"Sund","year":"2023","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ctrv.2025.102880_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.clbc.2023.08.003","article-title":"Safety and serum estradiol levels in hormonal treatments for vulvovaginal atrophy in breast cancer survivors: a systematic review and meta-analysis","author":"Comini","year":"2023","journal-title":"Clin Breast Cancer"},{"issue":"W64","key":"10.1016\/j.ctrv.2025.102880_b0095","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ctrv.2025.102880_b0100","unstructured":"The Ottawa Hospital Research Institute The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [Internet]. The Ottawa Hospital Research Institute. 2011; Available from: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp Date accessed: July 16, 2023 (Reference edited from original)."},{"key":"10.1016\/j.ctrv.2025.102880_b0105","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ctrv.2025.102880_b0110","unstructured":"Reeves BC, Deeks JJ, Higgins JPT, Shea B, Tugwell P, Wells GA. Chapter 24: Including non-randomized studies on intervention effects. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Smith GL. The long and short of tamoxifen therapy: a review of the ATLAS trial. Journal of the advanced practitioner in oncology. 2014 Jan;5(1):57."},{"key":"10.1016\/j.ctrv.2025.102880_b0115","first-page":"6","article-title":"Cochrane Handbook for Systematic Reviews of Intervention","author":"Li","year":"2022","journal-title":"Cochrane"},{"issue":"3","key":"10.1016\/j.ctrv.2025.102880_b0120","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/biomet\/70.3.659","article-title":"Discrete sequential boundaries for clinical trials","volume":"70","author":"Gordon Lan","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.ctrv.2025.102880_b0125","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10549-012-2198-y","article-title":"Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case\u2013control study","volume":"135","author":"Le Ray","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10.1016\/j.ctrv.2025.102880_b0130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.5694\/j.1326-5377.2002.tb04835.x","article-title":"Hormone replacement therapy after a diagnosis of breast cancer: cancer recurrence and mortality","volume":"177","author":"Mbioeth Durna","year":"2002","journal-title":"Med J Aust"},{"issue":"10","key":"10.1016\/j.ctrv.2025.102880_b0135","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/jnci\/93.10.754","article-title":"Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality","volume":"93","author":"O'Meara","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.ctrv.2025.102880_b0140","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/cmt.5.2.151.155","article-title":"Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study","volume":"5","author":"Dew","year":"2002","journal-title":"Climacteric"},{"key":"10.1016\/j.ctrv.2025.102880_b0145","unstructured":"Swedish National Guidelines for breast cancer (Nationellt v\u00e5rdprogram br\u00f6stcancer) (2020) https:\/\/kunskapsbanken.cancercentrum.se\/diagnoser\/brostcancer\/vardprogram\/. Accessed Mar 23 2022."},{"issue":"1","key":"10.1016\/j.ctrv.2025.102880_b0150","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/jamaoncol.2023.4508","article-title":"Vaginal estrogen therapy use and survival in females with breast cancer","volume":"10","author":"McVicker","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ctrv.2025.102880_b0155","first-page":"9","article-title":"268MO Safety of vaginal estrogen therapy after early-stage breast cancer: a nationwide population-based target trial emulation","volume":"1","author":"Dumas","year":"2024","journal-title":"ESMO Open"},{"issue":"3","key":"10.1016\/j.ctrv.2025.102880_b0160","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/SPV.0b013e3181d7e86e","article-title":"Systemic effects of topically administered estrogen therapy: a review","volume":"16","author":"Krause","year":"2010","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"17","key":"10.1016\/j.ctrv.2025.102880_b0165","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/j.ejca.2005.07.015","article-title":"Topical oestrogen therapy after breast cancer: is it safe?","volume":"41","author":"Ponzone","year":"2005","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.ctrv.2025.102880_b0170","doi-asserted-by":"crossref","first-page":"e1846","DOI":"10.1634\/theoncologist.2020-0417","volume":"25","author":"S\u00e1nchez-Rovira","year":"2020","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.ctrv.2025.102880_b0175","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.1016\/S1470-2045(20)30666-5","article-title":"Evidence-based approaches for the management of side-effects of adjuvant endocrine treatment in patients with breast cancer","volume":"22","author":"Franzoi","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2025.102880_b0180","article-title":"Advances in the management of menopausal symptoms, fertility preservation, and bone health for women with breast cancer on endocrine treatment","volume":"43","author":"Lambertini","year":"2023","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ctrv.2025.102880_b0185","first-page":"1","article-title":"Treating genitourinary syndrome of menopause in breast cancer survivors: main challenges and promising strategies","volume":"4","author":"Castelo-Branco","year":"2023","journal-title":"Climacteric"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737225000027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737225000027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T03:29:33Z","timestamp":1738812573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737225000027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":37,"alternative-id":["S0305737225000027"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2025.102880","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of topical estrogen therapy during adjuvant endocrine treatment among patients with breast cancer: A meta-analysis based expert panel discussion","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2025.102880","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102880"}}